Company: ABBV
Filing Date: 2025-08-04
Form Type: 10-Q
Source: 0001551152-25-000040
Chunk: 47

Company: AbbVie Inc.
Filing Date: 2025-08-04
Form: 10-Q
Item: Part I, Item 1
Chunk 47
---
million shares for $606 million during the six months ended June 30, 2025 and 5 million shares for $959 million during the six months ended June 30, 2024. AbbVie's remaining stock repurchase authorization was approximately $2.9 billion as of June 30, 2025.Accumulated Other Comprehensive Loss The following table summarizes the changes in each component of accumulated other comprehensive loss, net of tax, for the six months ended June 30, 2025:(in millions)Foreign currency translation adjustmentsNet investmenthedging activitiesPension and post-employment benefitsCash flow hedging activitiesTotalBalance as of December 31, 2024$(2,114)$549 $(664)$304 $(1,925)Other comprehensive income (loss) before reclassifications1,538 (925)1 (142)472 Net losses (gains) reclassified from accumulated other comprehensive loss— (56)1 (30)(85)Net current-period other comprehensive income (loss)1,538 (981)2 (172)387 Balance as of June 30, 2025$(576)$(432)$(662)$132 $(1,538)Other comprehensive income for the six months ended June 30, 2025 included foreign currency translation adjustments totaling a gain of $1.5 billion principally due to the impact of the strengthening of the Euro on the translation of the company’s Euro-denominated assets and the offsetting impact of net investment hedging activities totaling a loss of $981 million.

2025 Form 10-Q | 20

The following table summarizes the changes in each component of accumulated other comprehensive loss, net of tax, for the six months ended June 30, 2024:(in millions)Foreign currency translation adjustmentsNet investmenthedging activitiesPension and post-employment benefitsCash flow hedging activitiesTotalBalance as of December 31, 2023$(1,106)$65 $(1,488)$224 $(2,305)Other comprehensive income (loss) before reclassifications(553)336 5 62 (150)Net losses (gains) reclassified from accumulated other comprehensive loss— (45)13 (26)(58)Net current-period other comprehensive income (loss)(553)291 18 36 (208)Balance as of June 30, 2024$(1,659)$356